FR2818278B1 - Inhibiteurs de kinases dependantes des cyclines (cdk) et de la glycogene synthase kinase-3 (gsk-3) - Google Patents

Inhibiteurs de kinases dependantes des cyclines (cdk) et de la glycogene synthase kinase-3 (gsk-3)

Info

Publication number
FR2818278B1
FR2818278B1 FR0016632A FR0016632A FR2818278B1 FR 2818278 B1 FR2818278 B1 FR 2818278B1 FR 0016632 A FR0016632 A FR 0016632A FR 0016632 A FR0016632 A FR 0016632A FR 2818278 B1 FR2818278 B1 FR 2818278B1
Authority
FR
France
Prior art keywords
cdk
gsk
inhibitors
glycogen synthase
synthase kinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0016632A
Other languages
English (en)
Other versions
FR2818278A1 (fr
Inventor
Gregoire Prevost
Marie Odile Lonchampt
Sun Kim
Barry Morgan
Gerard Ulibarri
Christophe Thurieau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0016632A priority Critical patent/FR2818278B1/fr
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority to EP01994895A priority patent/EP1345941A1/fr
Priority to AU2509602A priority patent/AU2509602A/xx
Priority to US10/433,857 priority patent/US20040048849A1/en
Priority to PCT/FR2001/004048 priority patent/WO2002050079A1/fr
Priority to CA002432417A priority patent/CA2432417A1/fr
Priority to JP2002551972A priority patent/JP2004516297A/ja
Priority to AU2002225096A priority patent/AU2002225096B8/en
Priority to ARP010105967A priority patent/AR037485A1/es
Publication of FR2818278A1 publication Critical patent/FR2818278A1/fr
Application granted granted Critical
Publication of FR2818278B1 publication Critical patent/FR2818278B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0016632A 2000-12-20 2000-12-20 Inhibiteurs de kinases dependantes des cyclines (cdk) et de la glycogene synthase kinase-3 (gsk-3) Expired - Fee Related FR2818278B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0016632A FR2818278B1 (fr) 2000-12-20 2000-12-20 Inhibiteurs de kinases dependantes des cyclines (cdk) et de la glycogene synthase kinase-3 (gsk-3)
AU2509602A AU2509602A (en) 2000-12-20 2001-12-19 Cyclin-dependent kinase (CDK) and glycolene synthase kinase-3 (GSK-3) inhibitors
US10/433,857 US20040048849A1 (en) 2000-12-20 2001-12-19 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors
PCT/FR2001/004048 WO2002050079A1 (fr) 2000-12-20 2001-12-19 Inhibiteurs de kinases dependantes des cylines (cdk) et de la glycogene synthase kinase-3 (gsk-3)
EP01994895A EP1345941A1 (fr) 2000-12-20 2001-12-19 Inhibiteurs de kinases dependantes des cylines (cdk) et de la glycogene synthase kinase-3 (gsk-3)
CA002432417A CA2432417A1 (fr) 2000-12-20 2001-12-19 Inhibiteurs de kinases dependantes des cylines (cdk) et de la glycogene synthase kinase-3 (gsk-3)
JP2002551972A JP2004516297A (ja) 2000-12-20 2001-12-19 サイクリン依存性キナーゼ（ｃｄｋ）及びグリコーゲンシンターゼキナーゼ−３（ｇｓｋ−３）の阻害剤
AU2002225096A AU2002225096B8 (en) 2000-12-20 2001-12-19 Cyclin-dependent kinase (CDK) and glycogen synthase kinase-3 (GSK-3) inhibitors
ARP010105967A AR037485A1 (es) 2000-12-20 2001-12-20 Uso de un compuesto derivado de pirazol-triazina en la fabricacion de un medicamento, medicamento que comprende un compuesto derivado de pirazol-triazina, producto industrial y composicion farmaceutica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0016632A FR2818278B1 (fr) 2000-12-20 2000-12-20 Inhibiteurs de kinases dependantes des cyclines (cdk) et de la glycogene synthase kinase-3 (gsk-3)

Publications (2)

Publication Number Publication Date
FR2818278A1 FR2818278A1 (fr) 2002-06-21
FR2818278B1 true FR2818278B1 (fr) 2003-02-28

Family

ID=8857907

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0016632A Expired - Fee Related FR2818278B1 (fr) 2000-12-20 2000-12-20 Inhibiteurs de kinases dependantes des cyclines (cdk) et de la glycogene synthase kinase-3 (gsk-3)

Country Status (1)

Country Link
FR (1) FR2818278B1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101367820B (zh) * 2008-10-08 2010-09-15 苏州大学 吡唑并[1,5-a]吲哚三氟甲磺酸盐-4-二甲氨基苄烯衍生物及其制备方法
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
US8278450B2 (en) 2007-04-18 2012-10-02 Takeda Pharmaceutical Company Limited Kinase inhibitors
US8288536B2 (en) 2004-10-15 2012-10-16 Takeda Pharmaceutical Company Limited Kinase inhibitors

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112592346B (zh) * 2019-07-30 2022-04-26 厦门宝太生物科技股份有限公司 一种a2a和/或a2b抑制剂中间体的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166016A (en) * 1996-06-06 2000-12-26 Otsuka Pharmaceutical Factory, Inc. Amide derivatives
US5866702A (en) * 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2
WO1999002162A1 (fr) * 1997-07-12 1999-01-21 Cancer Research Campaign Technology Limited Derives de purine inhibant la kinase dependant de la cycline

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8288536B2 (en) 2004-10-15 2012-10-16 Takeda Pharmaceutical Company Limited Kinase inhibitors
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
US8278450B2 (en) 2007-04-18 2012-10-02 Takeda Pharmaceutical Company Limited Kinase inhibitors
CN101367820B (zh) * 2008-10-08 2010-09-15 苏州大学 吡唑并[1,5-a]吲哚三氟甲磺酸盐-4-二甲氨基苄烯衍生物及其制备方法

Also Published As

Publication number Publication date
FR2818278A1 (fr) 2002-06-21

Similar Documents

Publication Publication Date Title
HUP0302002A3 (en) Heterocyclic inhibitors of glycogen synthase kinase gsk-3, their use and pharmaceutical compositions containing them
IS2898B (is) 3,4-tvíútskipt 1H-pýrasólefnasambönd og notkun þeirra sem stillar sýklínháðra kínasar (CDK) og glýkógensýntasakínasa-3 (GSK-3) stillar
MXPA03006420A (es) Diaminotiazoles.
PL374023A1 (en) Inhibitors of jak and cdk2 protein kinases
NO20022864L (no) Aminotiazol inhibitorer av syklin uavhengig kinase
EP1490373A4 (fr) Inhibiteurs des nucleoside phosphorylases et nucleosidases
IL174431A0 (en) Substituted benzazoles and use thereof as inhibitors of raf kinase
AU2003251559A8 (en) Heterocyclic inhibitors of kinases
HK1160859A1 (en) Inhibitors of tyrosine kinases
DE60039616D1 (de) INHIBITOREN DER c-JUN N-TERMINALEN KINASE (JNK) UND ANDERE PROTEIN-KINASEN
HUP0300497A3 (en) Inhibitors of human phosphatidyl-inositol 3-kinase delta
AU2003282976A1 (en) Inhibitors of glycogen synthase kinase 3
HK1049661A1 (en) N-Ä5-ÄÄÄ5-alkyl-2-oxazolylÜmethylÜthioÜ-2-thiazolyn carboxamide inhibitors of cyclin dependent kinases.
WO2006125616A3 (fr) Methodes de traitement de la douleur
NO20024386L (no) Farmasöytiske sammensetninger av glycogenfosforylase- inhibitorer
IL166153A0 (en) Flavone derivatives as inhibitors of cyclin-dependent kinases
WO2008049856A3 (fr) Procédés pour le traitement de la douleur
MXPA03000774A (es) Inhibidores de n-[5-[[[5-alquil-2-oxazolil]metil]ito]-2-tiazolil]carboxamida de cinasas dependientes de la ciclina.
DK1157019T3 (da) 4-alkenyl- (og alkynyl-)oxindoler som inhibitorer af cyklinafhængige kinaser, især CDK2
SI1590360T1 (sl) Postopek priprave inhibitorjev nukleozidnih fosforilaz in nukleozidaz
WO2001037819A3 (fr) Utilisation de derives d'indirubine pour la fabrication de medicaments
EP1372654A4 (fr) Inhibiteurs quinoline des kinases hyak1 et hyak3
ATE382048T1 (de) Pyrazolopyrimdine als hemmstoffe cyclin abhängiger kinasen
PL369742A1 (en) Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
FR2818278B1 (fr) Inhibiteurs de kinases dependantes des cyclines (cdk) et de la glycogene synthase kinase-3 (gsk-3)

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
ST Notification of lapse

Effective date: 20120831